Estudios de caso
J.S. Held adquiere GLI Advisors para fortalecer sus servicios de apoyo a proyectos de construcción en el oeste de EE. UU. y Hawái
LEER MÁSThe client was a Clinical Stage Pharmaceutical Company with a promising cancer drug in Phase III testing before the Food & Drug Administration (FDA), based in Pennsylvania.
The Company raised more than $57 million of capital over a six-year period, and when our team was engaged in early 2003 had less than $3 million of cash remaining. The Company had recently withdrawn its registration statement for an IPO due to unfavorable market conditions and had been otherwise unsuccessful in attracting new capital or finalizing any licensing arrangements.
Our experts assisted with the right-sizing of the business and negotiated with a variety of suppliers and creditors to conserve cash. J.S. Held also assisted with the identification of potential purchasers and investors, and the negotiation and structuring of a pre-petition loan, stalking horse bid, and DIP loan from a publicly-traded pharmaceutical company. The offer consisted of $2.0 million of cash and potential future consideration based on licensing deals and achievement of certain sales thresholds that, based on a Monte Carlo simulation, had an additional net present value of $16.7 million. We helped develop the bidding and auction procedures and coordinated communication with 400+ potential purchasers. Two additional bids were received.
After 42 rounds of bidding, a winning bidder was selected with a bid that consisted of $7.5 million of cash and future consideration with an estimated additional NPV of $54.1 million. This 363 sale was consummated about 7 weeks after the Company filed its bankruptcy petition. Through our efforts, the value achieved for the unsecured creditors increased almost threefold from a cash perspective
Brian F. Gleason, CTP
Director ejecutivo sénior
Práctica de Asesoría Estratégica
+1 610 659 8118
[email protected]
> Asesoría sobre bancarrota
Navegar un proceso de bancarrota es inherentemente complejo, ya que suele involucrar empresas en dificultades, litigios, registros financieros incompletos o inexactos, posibles fraudes y otros desafíos, además de estrictos procesos impuestos por los tribunales. Nuestro equipo experimentado de expertos en reestructuración y recuperación orienta a los clientes de manera fluida a lo largo de todo el proceso para optimizar los resultados para prestamistas, acreedores, accionistas y empleados.
> Evaluación empresarial y operativa
La mayoría de las firmas de consultoría abordan la evaluación empresarial desde una perspectiva estrictamente financiera; nuestras evaluaciones proporcionan una visión de 360° de la empresa, que se ocupa de los impulsores de crecimiento, la rentabilidad y los usos del capital. Junto con revisiones detalladas del rendimiento financiero y previsiones de flujo de efectivo, nuestra evaluación empresarial y operativa integral identifica los diversos desafíos que enfrentan los clientes en sus operaciones.